增加脂肪移植的寿命和容量:临床实践中的进展
Pawan Acharya1, Cara Mohammed2, Arusha Desai3
1Surgery, Charing Cross Hospital, London, GBR.
Cureus
|August 25, 2025
概括
自体脂肪移植 (AFG) 的存活率通过生物增强,如富血小板血 (PRP) 和脂肪衍生干细胞 (AdSCs) 得到改善. 新兴的策略和特定部位的调整进一步提高了整形外科的脂肪保留和结果.
科学领域:
- 复原医学
- 整形外科
- 生物技术
背景情况:
- 自体脂肪移植 (AFG) 在美容和重建手术中被广泛使用.
- 不一致的移植保留仍然是一个重要的临床挑战.
- 生物相容性和再生特性推动了AFG的流行.
研究的目的:
- 审查改善脂肪移植存活率和体积保留的当代进展.
- 探索生物和新兴的增强脂肪移植活力的策略.
- 讨论特定地点的调整和未来的研究方向.
主要方法:
- 对脂肪移植增强技术的当前文献的审查.
- 生物增强的分析:富血小板血 (PRP),体血管分量 (SVF),脂肪衍生干细胞 (AdSCs).
- 探索新兴策略:维生素E (VE),紧脂肪接种,可溶性分子 (素,血管内皮生长因子),肉毒素A (BoNTA),缩脱油脂肪 (CDF) 和支架.
主要成果:
- 生物增强促进血管生成,减少纤维化,改善移植整合.
- 在实验和临床模型中,新兴的策略对移植存活有希望.
- 协同使用PRP和ADSC可增加生长因子表达和组织活力.
- 特定位置的适应增强了面,乳腺和部区域的区域移植活力.
结论:
- 生物和新兴策略的进步显著改善了脂肪移植的存活率和结果.
- 由于方法的异质性,标准化问题仍然存在.
- 需要进一步研究干细胞丰富,生物材料整合和长期验证的分子途径.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...